Real Chemistry cuts AI deployment time from months to weeks using Databricks platform
Real Chemistry is using Databricks Apps to deploy AI models that identify undiagnosed rare-disease patients and track patient journeys, according to a recent company post. The shift allows non-technical analysts to access these capabilities without waiting for engineering support.
The company previously spent six months to a year building custom applications. Proof-of-concept projects now launch within a week.
More than 200 users across Real Chemistry are running self-service AI workflows on the platform, suggesting growing adoption among healthcare organizations seeking faster access to specialized analytics.
What this means for healthcare professionals
Faster deployment of AI models directly affects your work. Analysts can build and test patient identification workflows without bottlenecks in the engineering queue. This reduces the time between identifying a clinical need and having tools to address it.
For organizations managing rare-disease diagnosis, the ability to analyze patient journeys at scale becomes a practical capability rather than a months-long project.
Broader implications
Real Chemistry's experience reflects a shift in how healthcare organizations approach data infrastructure. Rather than waiting for custom-built solutions, teams can now self-serve on platforms designed to handle both data analysis and AI model deployment.
This model works particularly well in healthcare, where clinical teams often understand their data questions better than engineering teams understand their clinical context.
Learn more about AI for Healthcare and Data Analysis to understand how these tools apply to your work.
Your membership also unlocks:
